Sign up for our newsletter and get Genome updates in your inbox.
By John Lugo
Based on positive results from the RESONATE clinical trial, the U.S. Food and Drug Administration has approved Imbruvica (ibrutinib) for treatment in chronic lymphocytic leukemia (CLL) patients who …